Legato Capital Management’s Merck MRK Stock Holding History

Legato Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.96M	Sell	30,800 -3,124	-9%	-$366K	0.33%	67
2026 Q1	$4.08M	Buy	33,924 +7,925	+30%	+$915K	0.37%	52
2025 Q4	$2.74M	Buy	25,999 +8,759	+51%	+$822K	0.24%	103
2025 Q3	$1.45M	Hold	17,240	–	–	0.16%	196
2025 Q2	$1.36M	Buy	17,240 +1,837	+12%	+$146K	0.16%	198
2025 Q1	$1.38M	Sell	15,403 -10,100	-40%	-$943K	0.19%	176
2024 Q4	$2.54M	Sell	25,503 -12,315	-33%	-$1.27M	0.33%	62
2024 Q3	$4.29M	Hold	37,818	–	–	0.53%	24
2024 Q2	$4.68M	Sell	37,818 -9,756	-21%	-$1.26M	0.63%	17
2024 Q1	$6.28M	Hold	47,574	–	–	0.76%	11
2023 Q4	$5.19M	Hold	47,574	–	–	0.68%	19
2023 Q3	$4.9M	Buy	47,574 +801	+2%	+$86.3K	0.71%	17
2023 Q2	$5.4M	Buy	46,773 +11,446	+32%	+$1.3M	0.73%	12
2023 Q1	$3.76M	Buy	35,327 +7,500	+27%	+$810K	0.68%	15
2022 Q4	$3.09M	Buy	+27,827	New	+$2.84M	0.59%	22

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Legato Capital Management's MRK Position: Q2 2026 in Review

Legato Capital Management reduced its Merck (MRK) stake by 9.2% in Q2 2026, selling an estimated $366K and leaving 30,800 shares worth $3.96M. The position accounts for 0.33% of the portfolio, ranked #67.

Legato Capital Management first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $6.28M in Q1 2024. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Legato Capital Management held 30,800 shares of Merck worth $3.96M as of Q2 2026.
Legato Capital Management sold 3,124 Merck shares in Q2 2026, an estimated $366K.
Merck made up 0.33% of Legato Capital Management's portfolio in Q2 2026, its #67 holding.
Legato Capital Management first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
Legato Capital Management's Merck position peaked at $6.28M in Q1 2024.
3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.